Cariprazine Monotherapy for the Treatment of Bipolar I Depression: Results: of an 8-Week, Double-blind, Placebo-controlled Study

被引：0
|
作者：
Calabrese, Joseph R. [1 ]
Durgam, Suresh [1 ]
Lipschitz, Alan [1 ]
Guo, Hua [1 ]
Earley, Willie [1 ]
Laszlovszky, Istvan [1 ]
Nemeth, Gyoergy [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2014年 / 39卷
关键词：
cariprazine; bipolar depression; dopamine;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T69
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled study of cariprazine monotherapy for the treatment of bipolar I depression
    Durgam, S.
    Lipschitz, A.
    Guo, H.
    Earley, W.
    Laszlovszky, I.
    Nemeth, G.
    Yatham, L. N.
    [J]. BIPOLAR DISORDERS, 2015, 17 : 90 - 91
  • [2] An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
    Durgam, Suresh
    Earley, Willie
    Lipschitz, Alan
    Guo, Hua
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Vieta, Eduard
    Calabrese, Joseph R.
    Yatham, Lakshmi N.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (03): : 271 - 281
  • [3] Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Sarma, K.
    Kroger, H.
    Calabrese, J. R.
    Sachs, G.
    [J]. BIPOLAR DISORDERS, 2013, 15 : 138 - 138
  • [4] Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
    Loebel, Antony
    Cucchiaro, Josephine
    Silva, Robert
    Kroger, Hans
    Hsu, Jay
    Sarma, Kaushik
    Sachs, Gary
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (02): : 160 - 168
  • [5] Lurasidone monotherapy in the treatment of bipolar I depression: Efficacy Results of a randomized, double-blind, placebo-controlled, 6-week elevate study
    Kato, T.
    Ishigooka, J.
    Masuda, T.
    Watabe, K.
    Fujimori, T.
    Higuchi, T.
    [J]. BIPOLAR DISORDERS, 2019, 21 : 131 - 131
  • [6] A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
    Calabrese, JR
    Bowden, CL
    Sachs, GS
    Ascher, JA
    Monaghan, E
    Rudd, GD
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) : 79 - +
  • [7] Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
    Earley, Willie
    Burgess, Maria Victoria
    Rekeda, Ludmyla
    Dickinson, Regan
    Szatmari, Balazs
    Nemeth, Gyorgy
    McIntyre, Roger S.
    Sachs, Gary S.
    Yatham, Lakshmi N.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06): : 439 - 448
  • [8] Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study
    Earley, Willie R.
    Burgess, Maria V.
    Khan, Barbara
    Rekeda, Ludmyla
    Suppes, Trisha
    Tohen, Mauricio
    Calabrese, Joseph R.
    [J]. BIPOLAR DISORDERS, 2020, 22 (04) : 372 - 384
  • [9] Lurasidone monotherapy in the treatment of bipolar I depression: Safety and tolerability Results of a randomized, double-blind, placebo-controlled, 6-week elevate study
    Kato, T.
    Ishigooka, J.
    Masuda, T.
    Watabe, K.
    Fujimori, T.
    Higuchi, T.
    [J]. BIPOLAR DISORDERS, 2019, 21 : 131 - 131
  • [10] Double-blind, placebo-controlled study of quetiapine in bipolar I depression
    Macfadden, W
    Calabrese, J
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S299 - S299
12345